Structural motifs determining the high anti-thrombin activity of NU172, an aptamer currently in Phase II clinical trials

MLA

Troisi Romualdo, et al. Structural Motifs Determining the High Anti-Thrombin Activity of NU172, an Aptamer Currently in Phase II Clinical Trials. Jan. 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......3730..7ffc53d3beafbb7201fa5e0dc19926f1&authtype=sso&custid=ns315887.

APA

Troisi Romualdo, Napolitano Valeria, Russo Krauss Irene, & Sica Filomena. (2018). Structural motifs determining the high anti-thrombin activity of NU172, an aptamer currently in Phase II clinical trials.

Chicago

Troisi Romualdo, Napolitano Valeria, Russo Krauss Irene, and Sica Filomena. 2018. “Structural Motifs Determining the High Anti-Thrombin Activity of NU172, an Aptamer Currently in Phase II Clinical Trials,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......3730..7ffc53d3beafbb7201fa5e0dc19926f1&authtype=sso&custid=ns315887.